BioStock: Cereno Scientific strengthens Scientific Advisory Board

This week, Cereno Scientific announced the appointment of the highly regarded Dr Raymond L. Benza to its Scientific Advisory Board (SAB), thus further expanding the company’s clinical expertise within cardiovascular diseases, in particular, pulmonary arterial hypertension (PAH). The appointment comes at a suitable timing, as Cereno Scientific is now gearing up for its planned phase II trial with drug candidate CS1 in PAH.

Read the full article at biostock.se:

https://www.biostock.se/en/cereno-scientific-strengthens-scientific-advisory-board/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se